Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Oocyte donation.

L M Talbert1

  • 1Department of Obstetrics & Gynecology, University of North Carolina, Chapel Hill 27599-7570.

Current Opinion in Obstetrics & Gynecology
|October 1, 1992
PubMed
Summary
This summary is machine-generated.

Donor oocyte programs are vital in assisted reproductive technology, offering higher pregnancy success rates. This approach benefits women with infertility due to ovarian failure, genetic issues, or advanced maternal age.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of metformin therapy on ovarian stimulation and outcome in 'coasted' patients with polycystic ovary syndrome undergoing in-vitro fertilization.

Reproductive biomedicine online·2002
Same author

Metformin treatment of patients with polycystic ovary syndrome undergoing in vitro fertilization improves outcomes and is associated with modulation of the insulin-like growth factors.

Fertility and sterility·2001
Same author

Cauterization of hydrosalpinges before in vitro fertilization is an effective surgical treatment associated with improved pregnancy rates.

American journal of obstetrics and gynecology·2000
Same author

A case of severe ovarian hyperstimulation in a healthy oocyte donor.

Fertility and sterility·1995
Same author

The use of donated oocytes for the treatment of infertility.

North Carolina medical journal·1994
Same author

The role of aerobic and anaerobic semen cultures in asymptomatic couples undergoing in vitro fertilization: effects on fertilization and pregnancy rates.

Fertility and sterility·1993
Same journal

Management of hypertensive disorders in pregnancy.

Current opinion in obstetrics & gynecology·2026
Same journal

Updates in group prenatal care research.

Current opinion in obstetrics & gynecology·2026
Same journal

Complex benign gynecology in perimenopause: current evidence and future directions.

Current opinion in obstetrics & gynecology·2026
Same journal

Role of insulin in female reproduction.

Current opinion in obstetrics & gynecology·2026
Same journal

Urinary tract involvement in endometriosis: current evidence and clinical insights into navigating diagnosis and management.

Current opinion in obstetrics & gynecology·2026
Same journal

Updates in ultrasound imaging of adenomyosis and clinical impacts.

Current opinion in obstetrics & gynecology·2026
See all related articles

Area of Science:

  • Reproductive Medicine
  • Assisted Reproductive Technology

Background:

  • Donor oocyte use is a growing component of assisted reproductive technology.
  • Key candidates include women with premature ovarian failure, genetic disorders, poor response to stimulation, or advanced maternal age.

Purpose of the Study:

  • To describe the indications and methods for donor oocyte programs.
  • To highlight the improved pregnancy rates compared to traditional in vitro fertilization.

Main Methods:

  • Coordination of donor and recipient cycles using pituitary desensitization with gonadotropin-releasing-hormone agonists.
  • Utilizing donor oocytes for in vitro fertilization and embryo transfer.

Main Results:

  • Pregnancy rates are significantly higher than with traditional in vitro fertilization and embryo transfer.

Related Experiment Videos

  • Potential reasons for success include younger donor age and improved endometrial receptivity.

    • Conclusions:

    • Donor oocyte programs represent an effective assisted reproductive technology strategy.
    • This method offers improved outcomes for specific patient populations facing infertility.